Generic Name: Roflumilast
Brand Name: Daxas
Manufacturer: Nycomed Canada Inc.
Therapeutic Area: Chronic obstructive pulmonary disease
Indications: Chronic obstructive pulmonary disease (COPD)
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: July 27, 2011
Recommendation Type: Do not list